4//SEC Filing
Marquess Dan 4
Accession 0000899243-20-009848
CIK 0001463361other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 5:09 PM ET
Size
8.0 KB
Accession
0000899243-20-009848
Insider Transaction Report
Form 4
Marquess Dan
Chief Scientific Officer
Transactions
- Award
Common Stock, $0.0001 par value
2020-03-30+24,255→ 381,297 total - Award
Stock Option (Right to Buy)
2020-03-30+98,490→ 98,490 totalExercise: $5.95Exp: 2030-03-29→ Common Stock (98,490 underlying)
Footnotes (3)
- [F1]Represents Restricted Stock Units ("RSUs") which vest in equal annual installments over a three year period measured from March 30, 2020. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]Includes 1 share acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2019. Also includes RSUs which vest over time measured from the grant date.
- [F3]Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 48-month period commencing on March 30, 2020 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001734423
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 5:09 PM ET
- Size
- 8.0 KB